Navigation Links
PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
Date:2/23/2012

more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Forward-looking StatementsThis press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Important factors that could impair the value of the Company's royalty assets, restrict or impede the ability of the Company to invest in new royalty bearing assets and limit the Company's ability to pay dividends are disclosed in the risk factors contained in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission and updated by subsequent Quarterly Reports on Form 10-Q. All forward-looking statements are expressly qualified in their entirety by such factors. We do not undertake any duty to update any forward-looking statement except as required by law.PDL BIOPHARMA, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS DATA(Unaudited)(In thousands, except per share amounts)Three Months EndedYear EndedDecember 31,December 31,2011201020112010RevenuesRoyalties$ 72,808$  74,629$ 351,641$ 343,475License and other-1,50010,4001,500Total revenues72,80876,129362,041344,975Operating ExpensesGeneral and administrative expenses4,82212,05618,33841,396Legal Settlement-92,500-92,500Total operating expenses4,822104,55618,338133,896Operating income (loss)67,986(28,427)343,703211,079Non-operating expense, netGain (loss) on retirement or conversion of convertible notes-1,033(766)(17,648)Interest and other income, net130131593468Interest expense(8,161)(9,514)(36,102)(43,529)Total non-operating expense, net(8,031)(8,350)(36,275)(60,709)Income befor
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
3. Ondine Biopharma Announces Second Quarter 2008 Financial Results
4. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
7. Therapure Biopharma Inc. opens for business with first client contracts
8. Top Biopharma Company Adopts BioFortis Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
9. China Biopharma Effects 1 for 100 Reverse Stock Split
10. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
11. FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, Inc., the ... relaunch of his highly informative blog, now named Stem Cells ... are Stem Cells ?” Dr. Harman’s purpose for blogging ... basics of stem cell therapy so that pet owners can ... when considering regenerative medicine. , A veterinarian by trade, Dr. ...
(Date:7/10/2014)... ST. PETERSBURG, Russia , July 10, 2014 /PRNewswire/ ... the Russian Federation Dmitry Medvedev , presented ... a biopharmaceutical company BIOCAD . The Company is ... the scope of MabNext project BIOCAD develops a number ... of cancer and autoimmune diseases. The ceremony took place ...
(Date:7/10/2014)... 2014 -- According to the International Atomic Energy ... comes from terrorists acquiring sufficient quantities of plutonium ... crude nuclear explosive device. The IAEA also notes ... involved gram-level quantities, which can be challenging to ... a new study appearing this week in the ...
(Date:7/10/2014)... have observed the fractional quantum Hall effect in bilayer ... can be tuned by an electric field. , ... electrons confined to thin sheets are exposed to large ... where thousands of individual electrons behave as a single ... is well established, many details of this collective behavior ...
Breaking Biology Technology:Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Sensitive detection method may help impede illicit nuclear trafficking 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3
... US: CXM) today announced the completion of a $3.5 million ... to purchase shares of common stock. Empire Asset Management Company ... transaction. The material terms of the credit facility are ... Form 8-K to be filed with the Securities and Exchange ...
... KENILWORTH, N.J., March 5 Schering-Plough Corporation (NYSE: ... of a presentation by David Nicholson, Ph.D., senior vice ... Institute, at the Barclays Capital Global Healthcare Conference in ... EDT. Nicholson is expected to talk about the ...
... Experts from PAREXEL International Corporation (Nasdaq: ... will address important industry issues at the Drug ... from March 23 - 25, 2009 in Berlin, ... present on topics ranging from global biosimilar development ...
Cached Biology Technology:Cardium Completes $3.5 Million Credit Facility 2Cardium Completes $3.5 Million Credit Facility 3Cardium Completes $3.5 Million Credit Facility 4PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 2PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 3PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 4PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 5
(Date:7/11/2014)... This news release is available in German . ... imaging is a method that uses the refraction of ... absorption. The images produced with this method are often ... The scientists in the team of Prof. Franz Pfeiffer ... X-ray imaging and therapy including X-ray phase-contrast imaging. ...
(Date:7/11/2014)... 3, 2014, Shenzhen, China Researchers from Salk Institute ... the first time evaluated the safety and reliability ... successfully developed a new method, TALEN-HDAdV, which could ... stem cell (hiPSC). This study published online in ... theoretical foundation for stem cell-based gene therapy. , ...
(Date:7/11/2014)... 11, 2014 Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... NY) Many egg donation agencies and private couples routinely ... study finds. From a sample of over 300 ... offered payment in excess of $10,000, a violation of ... (ASRM). Compensation strongly correlated with average ...
... PITTSBURGH, March 24 An experimental vaccine against an ... delay the onset of inflammatory bowel disease (IBD) and in ... the University of Pittsburgh School of Medicine. Their findings are ... journal of the American Association for Cancer Research. People ...
... weather in the Canadian Arctic could create problems for nesting ... have spent over 7,000 days observing birds in the North. ... cold, dry summers that mark the high Arctic. However, warmer ... fog, rain, freezing rain, wet snow and stronger winds. ...
Cached Biology News:Fertility industry offers big money to recruit 'desirable' egg donors at top universities 2Vaccine could delay bowel inflammation and colon cancer, says Pitt research 2Warmer summers could create challenges for nesting Arctic seabirds 2Warmer summers could create challenges for nesting Arctic seabirds 3
Mouse monoclonal antibody to QARS - glutaminyl-tRNA synthetase...
... DNA polymerase obtained by high level expression ... E. coli, Concentration: 5U/ul, Applications: Standard PCR ... the world leader in serving science. Thermo ... world healthier, cleaner and safer by providing ...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
... MasterAmp™ Taq DNA Polymerase is a ... aquaticus. Having optimal activity at temperatures ... thermostable enzyme used for PCR and ... purpose. The enzyme has an intrinsic ...
Biology Products: